Daiwa Securities Group
RYTM icon

Daiwa Securities Group’s Rhythm Pharmaceuticals RYTM Stock Holding History

Daiwa Securities Group’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-201
Closed -$22K – 1398
2025
Q4 		$22K Sell
201
-12
-6% -$1.27K ﹤0.01% 1155
2025
Q3 		$22K Sell
213
-16
-7% -$1.49K ﹤0.01% 1135
2025
Q2 		$14K Buy
229
+26
+13% +$1.59K ﹤0.01% 1109
2025
Q1 		$11K Hold
203
– – ﹤0.01% 1091
2024
Q4 		$11K Sell
203
-24
-11% -$1.33K ﹤0.01% 1114
2024
Q3 		$12K Hold
227
– – ﹤0.01% 1122
2024
Q2 		$9K Hold
227
– – ﹤0.01% 1170
2024
Q1 		$10K Hold
227
– – ﹤0.01% 1166
2023
Q4 		$10K Hold
227
– – ﹤0.01% 1170
2023
Q3 		$5K Hold
227
– – ﹤0.01% 1162
2023
Q2 		$4K Hold
227
– – ﹤0.01% 1203
2023
Q1 		$4K Hold
227
– – ﹤0.01% 1168
2022
Q4 		$7K Buy
227
+55
+32% +$1.41K ﹤0.01% 1135
2022
Q3 		$4K Hold
172
– – ﹤0.01% 1181
2022
Q2 		$1K Hold
172
– – ﹤0.01% 1320
2022
Q1 		$2K Hold
172
– – ﹤0.01% 1270
2021
Q4 		$2K Hold
172
– – ﹤0.01% 1297
2021
Q3 		$2K Buy
172
+74
+76% +$1.13K ﹤0.01% 1247
2021
Q2 		$2K Hold
98
– – ﹤0.01% 1155
2021
Q1 		$2K Buy
98
+15
+18% +$435 ﹤0.01% 1161
2020
Q4 		$2K Sell
83
-165
-67% -$4.19K ﹤0.01% 1137
2020
Q3 		$5K Hold
248
– – ﹤0.01% 1095
2020
Q2 		$4K Hold
248
– – ﹤0.01% 1126
2020
Q1 		$4K Hold
248
– – ﹤0.01% 1122
2019
Q4 		$6K Buy
248
+29
+13% +$644 ﹤0.01% 1097
2019
Q3 		$5K Hold
219
– – ﹤0.01% 1076
2019
Q2 		$5K Hold
219
– – ﹤0.01% 1103
2019
Q1 		$6K Sell
219
-81
-27% -$2.33K ﹤0.01% 1068
2018
Q4 		$8K Buy
+300
New +$8.29K ﹤0.01% 1013

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Daiwa Securities Group's RYTM Position: Q1 2026 in Review

Daiwa Securities Group sold out of Rhythm Pharmaceuticals (RYTM) in Q1 2026, closing a stake of 201 shares — an estimated $22K sold.

Daiwa Securities Group first reported a position in RYTM in Q4 2018 and held it in 29 quarters. The position peaked at $22K in Q4 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Daiwa Securities Group reported no remaining Rhythm Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 201 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $22K.
  • Daiwa Securities Group first reported a position in Rhythm Pharmaceuticals in Q4 2018 and held it in 29 quarters.
  • Daiwa Securities Group's Rhythm Pharmaceuticals position peaked at $22K in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.